Inhaled corticosteroids in pulmonary sarcoidosis.
作者信息
Spiteri M A
出版信息
Postgrad Med J. 1991 Apr;67(786):327-9. doi: 10.1136/pgmj.67.786.327.
Abstract
摘要
相似文献
1
Inhaled corticosteroids in pulmonary sarcoidosis.肺结节病中的吸入性糖皮质激素。
Postgrad Med J. 1991 Apr;67(786):327-9. doi: 10.1136/pgmj.67.786.327.
2
Inhaled corticosteroids and pulmonary sarcoidosis.吸入性糖皮质激素与肺结节病
Sarcoidosis. 1988 Sep;5(2):104-5.
3
Inhaled budesonide influences cellular and biochemical abnormalities in pulmonary sarcoidosis.
Sarcoidosis. 1988 Sep;5(2):106-10.
4
Pulmonary sarcoidosis: a prospective evaluation of glucocorticoid therapy.肺结节病：糖皮质激素治疗的前瞻性评估
Md State Med J. 1971 Mar;20(3):101-2.
5
[Treatment of pulmonary sarcoidosis].[肺结节病的治疗]
Naika. 1967 Jun;19(6):1157-9.
6
[Treatment of pulmonary sarcoidosis].[肺结节病的治疗]
Poumon Coeur. 1967;23(5):609-29.
7
[Treatment of pulmonary sarcoidosis].
Iryo. 1968 May;22(5):625-30.
8
Oral and inhaled corticosteroids in the treatment of pulmonary sarcoidosis--a critical reappraisal.口服和吸入性皮质类固醇治疗肺结节病——一项批判性重新评估
Sarcoidosis Vasc Diffuse Lung Dis. 1998 Sep;15(2):150-7.
9
Sarcoidosis and steroids.结节病与类固醇。
Chest. 1983 Feb;83(2):289-90. doi: 10.1378/chest.83.2.289.
10
[Studies of the effectiveness and the practical application of glucocorticosteroid treatment in sarcoidosis (Boeck's disease)].[糖皮质激素治疗结节病（伯克氏病）的有效性及实际应用研究]
Z Tuberk Erkr Thoraxorg. 1967;126(5):281-90.
本文引用的文献
1
Beclomethasone dipropionate.二丙酸倍氯米松
Ann Intern Med. 1981 Oct;95(4):464-7. doi: 10.7326/0003-4819-95-4-464.
2
Alveolar macrophages in idiopathic pulmonary fibrosis have glucocorticoid receptors, but glucocorticoid therapy does not suppress alveolar macrophage release of fibronectin and alveolar macrophage derived growth factor.特发性肺纤维化中的肺泡巨噬细胞具有糖皮质激素受体，但糖皮质激素治疗并不能抑制肺泡巨噬细胞释放纤连蛋白和肺泡巨噬细胞衍生生长因子。
Am Rev Respir Dis. 1984 Sep;130(3):450-6. doi: 10.1164/arrd.1984.130.3.450.
3
Pathogenesis of the granulomatous lung diseases.肉芽肿性肺病的发病机制。
Am Rev Respir Dis. 1984 Sep;130(3):476-96. doi: 10.1164/arrd.1984.130.3.476.
4
Alveolar T-cell subsets in pulmonary sarcoidosis. Correlation with disease activity and effect of steroid treatment.结节病患者肺泡T细胞亚群。与疾病活动度的相关性及类固醇治疗的效果
Am Rev Respir Dis. 1984 Apr;129(4):563-8.
5
Immunocompetent cells in bronchoalveolar lavage reflect the cell populations in transbronchial biopsies in pulmonary sarcoidosis.支气管肺泡灌洗中的免疫活性细胞反映了肺结节病经支气管活检中的细胞群。
Am Rev Respir Dis. 1985 Dec;132(6):1300-6. doi: 10.1164/arrd.1985.132.6.1300.
6
7
Use of budesonide in the treatment of pulmonary sarcoidosis.
Ann N Y Acad Sci. 1986;465:713-21. doi: 10.1111/j.1749-6632.1986.tb18550.x.
8
Relation between immunocytological features of bronchoalveolar lavage fluid and clinical indices in sarcoidosis.结节病中支气管肺泡灌洗液体细胞免疫特征与临床指标的关系
Thorax. 1989 Jun;44(6):501-9. doi: 10.1136/thx.44.6.501.
9
The macrophage in sarcoid granuloma formation.结节病肉芽肿形成中的巨噬细胞。
Sarcoidosis. 1989 Oct;6 Suppl 1:12-4.
10
Inhaled corticosteroids can modulate the immunopathogenesis of pulmonary sarcoidosis.
Eur Respir J. 1989 Mar;2(3):218-24.
Zotero 插件